McDonough John 4
4 · T2 Biosystems, Inc. · Filed Jan 27, 2020
Insider Transaction Report
Form 4
McDonough John
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2020-01-23$1.15/sh−57,417$66,030→ 512,868 total
Footnotes (2)
- [F1]The transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 11, 2018.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.10 to $1.20. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each price within the range set forth in this footnote.